Residual lipidic risk beyond low-density lipoprotein cholesterol: new challenges and opportunities

This document explores residual lipidic risk beyond low-density lipoprotein cholesterol and presents new challenges and opportunities.


Residual lipidic risk beyond low-density lipoprotein cholesterol: new challenges and opportunities - cover page
Brand
European Society of Cardiology
Document type
Other
Language
English
Pages
4
File format
PDF
File size
4.7 MB
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
6175D7C59B9D6320A7C1905DE694BA53

About this manual

This European Heart Journal "Issue @ a Glance" editorial introduces a focus issue on dyslipidaemias, diabetes, and metabolic disorders. It summarizes several articles, including ESC guidelines on infective endocarditis and cardiovascular disease in patients with diabetes.

The editorial also highlights cardiometabolic risk management, sex-specific lipid and atherosclerotic cardiovascular disease risk in women, and a Copenhagen General Population Study analysis of triglyceride metabolism and mortality.

What's inside

  • Issue @ a Glance
  • Infective endocarditis
  • Cardiovascular disease in diabetes
  • Cardiometabolic risk management
  • Women, lipids, and atherosclerotic cardiovascular disease
  • Triglyceride metabolism and mortality

Frequently asked questions

What was the estimated incidence of infective endocarditis in 2019?

The estimated incidence was 13.8 cases per 100 000 subjects per year.

How many individuals were included in the Copenhagen General Population Study analysis?

The study included 30 000 individuals nested within 109 751 individuals.

What was the multivariable adjusted hazard ratio for all-cause mortality for the highest versus lowest glycerol fourth?

The hazard ratio was 1.31.

Download PDF (4.7 MB)